X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aromatase inhibitors (17) 17
cancer du sein (13) 13
inhibiteurs de l’aromatase (12) 12
breast cancer (8) 8
hormonothérapie (6) 6
arthralgia (5) 5
index medicus (5) 5
medicine & public health (5) 5
oncology (5) 5
aromatase (4) 4
aromatase inhibitor (4) 4
inhibiteur de l’aromatase (4) 4
ostéoporose (4) 4
tamoxifen (4) 4
tamoxifène (4) 4
arthralgies (3) 3
chemistry, multidisciplinary (3) 3
diabetes (3) 3
inhibiteur (3) 3
medicine (3) 3
osteoporosis (3) 3
testosterone (3) 3
testostérone (3) 3
agonistes de la gnrh (2) 2
animal models (2) 2
animals (2) 2
arthralgie (2) 2
binding (2) 2
breast-cancer (2) 2
cytokines (2) 2
derivatives (2) 2
endocrinology & metabolism (2) 2
estradiol (2) 2
gnrh agonists (2) 2
health aspects (2) 2
inflammation (2) 2
inhibiteurs d’aromatase (2) 2
inhibitor (2) 2
inhibitors (2) 2
interleukin (2) 2
internal medicine (2) 2
male (2) 2
men (2) 2
oxidative stress (2) 2
pharmacology (2) 2
pharmacology & pharmacy (2) 2
physiology (2) 2
prostate cancer (2) 2
prévention (2) 2
rats (2) 2
serm (2) 2
stress oxydatif (2) 2
toxicity (2) 2
17 beta-hydroxysteroid dehydrogenase (1) 1
17 β-hydroxysteroid dehydrogenase (1) 1
17 β-hydroxystéroïde déshydrogénase (1) 1
17β-hydroxysteroid dehydrogenase (1) 1
2d-qsar (1) 1
3d-qsar comparative molecular field analysis (1) 1
[ sdv.bdd ] life sciences [q-bio]/development biology (1) 1
[ sdv.bdd.eo ] life sciences [q-bio]/development biology/embryology and organogenesis (1) 1
[ sdv.tox ] life sciences [q-bio]/toxicology (1) 1
[ sdv.tox.eco ] life sciences [q-bio]/toxicology/ecotoxicology (1) 1
[sdv.bdd.eo]life sciences [q-bio]/development biology/embryology and organogenesis (1) 1
[sdv.bdd]life sciences [q-bio]/development biology (1) 1
[sdv.tox.eco]life sciences [q-bio]/toxicology/ecotoxicology (1) 1
[sdv.tox]life sciences [q-bio]/toxicology (1) 1
abnormalities (1) 1
acids (1) 1
activateur du plasminogène tissulaire (1) 1
adult (1) 1
affinity (1) 1
aldosterone synthase cyp11b2 (1) 1
alterations (1) 1
amarrage moléculaire (1) 1
analogues de la gnrh (1) 1
analogues de la lh-rh (1) 1
anastrozole (1) 1
anatomy (1) 1
androgen receptor (1) 1
androgens (1) 1
angiotensin (1) 1
angiotensin ii (1) 1
angiotensin ii - blood (1) 1
angiotensine ii (1) 1
angiotensins - antagonists & inhibitors (1) 1
animals, genetically modified (1) 1
anti-estrogènes purs (1) 1
anti-inflammatory agents (1) 1
anti-œstrogènes (1) 1
antiestrogens (1) 1
antihormones (1) 1
antioxidants (1) 1
antiprogestin ru486 (1) 1
approche de combinaison substructures (1) 1
assessment (1) 1
b cells (1) 1
beta cells (1) 1
biochemistry (1) 1
biological evaluation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Canadian Journal of Physiology and Pharmacology, ISSN 0008-4212, 2019, Volume 97, Issue 8, pp. 708 - 720
This study examined the effect of the aromatase inhibitor letrozole (0.5 mg/kg) alone or in combination with the angiotensin-receptor blocker valsartan (30... 
néphropathie diabétique | testosterone | inflammatory cytokines | rein | stress oxydatif | inhibiteur de l’aromatase | cytokines inflammatoires | kidney | hypogonadisme | hypogonadism | angiotensin II | valsartan | angiotensine II | testostérone | diabetic nephropathy | oxidative stress | aromatase inhibitor | estradiol | PHYSIOLOGY | RENAL-FUNCTION | INJURY | GLOMERULAR HYPERFILTRATION | II CONTRIBUTES | REPLACEMENT | MEN | PHARMACOLOGY & PHARMACY | TESTOSTERONE LEVELS | DIHYDROTESTOSTERONE | Collagen Type IV - blood | Estradiol - blood | Kidney - pathology | Glycated Hemoglobin A - metabolism | Letrozole - therapeutic use | Angiotensin II - blood | Diabetic Nephropathies - drug therapy | Male | NF-kappa B - metabolism | Letrozole - pharmacology | Valsartan - pharmacology | Kidney - metabolism | Valsartan - therapeutic use | Follicle Stimulating Hormone - blood | Testosterone - blood | Transforming Growth Factor beta1 - blood | Angiotensins - antagonists & inhibitors | Diabetic Nephropathies - pathology | Kidney - drug effects | Luteinizing Hormone - blood | Diabetic Nephropathies - metabolism | Rats | Diabetic Nephropathies - complications | Organ Size - drug effects | Animals | Signal Transduction - drug effects | Hypogonadism - complications | Oxidative Stress - drug effects | Pituitary hormones | Valsartan | Diabetic nephropathies | Superoxide | Glycoproteins | Inflammation | B cells | Transforming growth factors | Estradiol | Testosterone | Urea | Interleukins | Collagen | Angiotensin | Bone morphogenetic proteins | Cetrorelix | Oxidative stress | Normalizing | Interleukin | Chains | Superoxide dismutase | Hormones | Interleukin 6 | Rodents | Aromatase | Luteinizing hormone | Collagen (type IV) | Peroxidase | Physiology | Inhibition | Angiotensin II | Growth factors | Glutathione | Creatinine | Glutathione peroxidase | NF-κB protein | Level (quantity) | Kidneys | Cytokines | Diabetes mellitus | Pharmacology | Malondialdehyde | Hypogonadism | Beta cells | Nephropathy | Luteinizing hormone-releasing hormone | Diabetes | Hypertrophy | Proteinuria
Journal Article
Gynécologie Obstétrique & Fertilité, ISSN 1297-9589, 2005, Volume 33, Issue 5, pp. 348 - 355
Les inhibiteurs de l'aromatase (IA) bloquent la production d'estrogènes en inhibant la dernière étape enzymatique nécessaire à leur production, l'aromatisation... 
Inhibiteur | Ovulation induction | Aromatase | Induction de l'ovulation | Inhibitor | Ovulation | PCOD | Unexplained infertility | Infertilité inexpliquée
Journal Article
Annals of Endocrinology (Annales D'Endocrinologie, English Edition), ISSN 0003-4266, 2014, Volume 75, Issue 3, pp. 148 - 155
Abstract Breast cancer prevention can be provided by using SERMs or aromatase inhibitors depending on the ovarian status, with a global risk reduction of 50 to... 
Internal Medicine | Endocrinology & Metabolism | Prevention | Antihormones | Prévention | Breast | Cancer du sein | Inhibiteur de l’aromatase | SERM | Cancer | METFORMIN | ESTROGEN-RECEPTOR MODULATORS | RISK | PROLACTIN | DRUG INSIGHT | ENDOCRINOLOGY & METABOLISM | REPLACEMENT THERAPY | ANTIPROGESTIN RU486 | PROGESTIN | POSTMENOPAUSAL WOMEN | AROMATASE INHIBITORS
Journal Article
Revue du Rhumatisme monographies, ISSN 1878-6227, 2011, Volume 78, Issue 2, pp. 81 - 87
L’utilisation des inhibiteurs de l’aromatase est fréquente chez la femme ménopausée en traitement adjuvant au cours du cancer du sein. Empêchant la... 
Osteoporosis | Inhibiteurs de l’aromatase | Cancer du sein | Breast cancer | GnRH analogues | Ostéoporose | Prostate cancer | Analogues de la GnRH | Cancer de prostate | Aromatase inhibitors
Journal Article
Oncologie, ISSN 1292-3818, 6/2012, Volume 14, Issue 6, pp. 365 - 373
After a decade of endocrine adjuvant treatment with AI (Aromatase inhibitors), it is documented that they are somewhat superior to tamoxifen, in postmenopausal... 
Efficacité tolérance observance | Medicine & Public Health | Arthralgia | Oncology | Arthralgies | Effectiveness tolerance adherence | Inhibiteurs d’aromatase | Aromatase inhibitors
Journal Article
Oncologie, ISSN 1292-3818, 1/2009, Volume 11, Issue 1, pp. 33 - 36
Aromatase inhibitors (AIs) are widely used as adjuvant endocrine treatment in postmenopausal women with a breast cancer at early stage, with the presence of... 
Aromatase inhibitor | Medicine & Public Health | Arthralgia | Oncology | Arthralgies | Inhibiteur de l’aromatase | Symptômes musculosquelettiques | Musculoskeletal symptoms
Journal Article
La Revue de médecine interne, ISSN 0248-8663, 2004, Volume 25, Issue 4, pp. 323 - 324
Journal Article
ONCOLOGIE, ISSN 1292-3818, 3/2004, Volume 6, Issue 2, pp. 114 - 119
L’hormonothérapie palliative donne actuellement au praticien cinq, voire six armes thérapeutiques qu’il doit administrer à bon escient. Pour ce faire, il doit... 
Medicine | Inhibiteurs de l’aromatase | Pure anti-oestrogens | Progestins | Anti-estrogènes purs | Progestatifs | SERM | Palliative strategy | Hormonothérapie palliative | Aromatase inhibitors
Journal Article
Gynécologie Obstétrique & Fertilité, ISSN 1297-9589, 11/2012, Volume 40, Issue 11, pp. 631 - 633
Journal Article
Journal de Gynécologie Obstétrique et Biologie de la Reproduction, ISSN 0368-2315, 12/2010, Volume 39, Issue 8, pp. F71 - F78
Journal Article
Gynécologie Obstétrique & Fertilité, ISSN 1297-9589, 2009, Volume 37, Issue 5, pp. 447 - 451
Une analyse descriptive des données de la littérature concernant les cas rapportés de carcinosarcomes utérins survenus chez des patientes ayant eu une... 
Tamoxifène | Uterine carcinosarcoma | Inhibiteurs de l’aromatase | Carcinosarcome utérin | Cancer du sein | Breast cancer | Tamoxifen | Aromatase inhibitors
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2007, Volume 74, Issue 12, pp. 1340 - 1341
Journal Article
Oncologie, ISSN 1292-3818, 10/2007, Volume 9, Issue S3, pp. 5 - 10
Les inhibiteurs de l’aromatase ont optimisé le pronostic du cancer du sein chez la femme ménopausée. Ils exposent cependant à des troubles... 
Inhibiteurs de l’aromatase | Medicine & Public Health | Arthralgia | Cancer du sein | Hormonothérapie | Oncology | Arthralgie | Breast cancer hormonotherapy | Aromatase inhibitors
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 2008, Volume 75, Issue 6, pp. 546 - 551
Journal Article
by Briot, K and Roux, C
Oncologie, ISSN 1292-3818, 1/2009, Volume 11, Issue 1, pp. 28 - 32
The use of hormonal deprivation therapy in the management of breast and prostate cancers is associated with an increased risk of fracture and accelerated bone... 
Osteoporosis | GnRH agonists | Inhibiteurs de l’aromatase | Medicine & Public Health | Agonistes de la GnRH | Oncology | Fracture | Ostéoporose | Aromatase inhibitors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.